<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03246893</url>
  </required_header>
  <id_info>
    <org_study_id>Si212/2017</org_study_id>
    <nct_id>NCT03246893</nct_id>
  </id_info>
  <brief_title>Efficacy of HFNC Versus NIV for Prevent Reintubation in Sepsis Patients</brief_title>
  <official_title>Efficacy of High Flow Oxygen Nasal Cannula Versus Noninvasive Positive Pressure Ventilation After Extubation in Sepsis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post extubation respiratory failure occur in 30% of extubated patients. More than 50% of them
      required reintubation. Noninvasive positive pressure ventilation (NIV) had been reported as
      an effective tool to prevent post extubation respiratory failure. Recently, high flow oxygen
      nasal cannula (HFNC) had been successfully used to prevent post extubation respiratory
      failure and prevent reintubation in comparable with NIV among post cardiothoracic surgery and
      high risk for reintubated patients. There was no information about HFNC versus NIV in
      prevention of reintubation among severe sepsis or septic shock patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post extubation respiratory failure occur in 30% of extubated patients. More than 50% of them
      required reintubation. Noninvasive positive pressure ventilation (NIV) had been reported as
      an effective tool to prevent post extubation respiratory failure. Recently, high flow oxygen
      nasal cannula (HFNC) had been successfully used to prevent post extubation respiratory
      failure and prevent reintubation. The results from recent randomized controlled trials,
      comparing HFNC with NIV for prevent post extubation respiratory failure among post cardiac
      surgery and high risk patients, showed no significant different in the treatment
      outcome.comparable with NIV among post cardiothoracic surgery and high risk for reintubated
      patients.

      About 40-85% of severe sepsis/septic shock patients developed acute respiratory failure,
      required endotracheal intubation. According to the nature of patients population, usually
      eldery, multiple co-morbid condition and high APACHE II score, sepsis patients were
      considerred as high risk for reintubation, after extubated. There was no information about
      HFNC versus NIV in prevention of reintubation among severe sepsis or septic shock patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Device failure rate</measure>
    <time_frame>an average of 1 year</time_frame>
    <description>Device failure to prevent reintubation, patient discomfort, change to another device within 72 hours after extubation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reintubation rate</measure>
    <time_frame>an average of 1 year</time_frame>
    <description>Patient develope respiratory failure, requiring reintubation within 72 hours after extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28 day mortality rate</measure>
    <time_frame>Upto 28 days</time_frame>
    <description>Proportion of dead patients to overall patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital mortality rate</measure>
    <time_frame>an average of 1 year</time_frame>
    <description>Proportion of dead patients to overall patients from extubation to discharge date</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Post Extubation Respiratory Failure</condition>
  <condition>Re-intubation</condition>
  <condition>Septic Shock</condition>
  <condition>Severe Sepsis</condition>
  <arm_group>
    <arm_group_label>Noninvasive positive pressure ventilation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After extubation, patient will receive non invasive positive pressure ventilation (NIV) for prevent respiratory and reintubation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High flow oxygen nasal cannula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After extubation, patient will receive high flow oxygen cannula for prevent respiratory and reintubation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Noninvasive positive pressure ventilation</intervention_name>
    <description>Noninvasive positive pressure ventilation will apply via a face mask with initial setting as the following:
Inspiratory pressure 6-8 cmH2O Expiratory pressure 3-5 cmH2O FiO2 30-60% Respiratory rate 12-16 per min</description>
    <arm_group_label>Noninvasive positive pressure ventilation</arm_group_label>
    <other_name>NIV</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High flow oxygen nasal cannula</intervention_name>
    <description>High flow oxygen nasal cannula will apply to patient via a nasal cannula with initial setting as the following:
Temperature 37 degree celsius Flow 30 liter per min FiO2 40-60%</description>
    <arm_group_label>High flow oxygen nasal cannula</arm_group_label>
    <other_name>HFNC</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of sepsis or septic shock according to the Third International Consensus
             Definitions for Sepsis and Septic Shock (Sepsis-3)

          -  Depended on mechanical ventilator for more than 48 hours

          -  Plan for extubation due to successful weaning

        Exclusion Criteria:

          -  Patient with tracheostomy

          -  Recent upper abdominal surgery

          -  Wound at face that prohibit face-mask application

          -  Patient or 1st degree relative not agree to participate trial

          -  Physician prefer either NIV or HFNC for the patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Surat Tongyoo, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Siriraj Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Surat Tongyoo, Dr</last_name>
    <phone>+6624198534</phone>
    <email>surat_Ty@yahoo.co.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tanuwong Viarasilpa, Dr</last_name>
    <phone>+6624197764</phone>
    <email>tanuwong.via@mahidol.co.th</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Surat Tongyoo, MD</last_name>
      <phone>6624198534</phone>
      <email>surat_Ty@yahoo.co.uk</email>
    </contact>
    <investigator>
      <last_name>Tanuwong Vialasilpa, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kiatchai Dawratanachai, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chairat Permpikul, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.</citation>
    <PMID>26903338</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2017</study_first_submitted>
  <study_first_submitted_qc>August 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 11, 2017</study_first_posted>
  <last_update_submitted>August 8, 2017</last_update_submitted>
  <last_update_submitted_qc>August 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Surat Tongyoo</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>Septic shock</keyword>
  <keyword>Severe sepsis</keyword>
  <keyword>Extubation</keyword>
  <keyword>Reintubation</keyword>
  <keyword>Noninvasive positive pressure ventilation</keyword>
  <keyword>High flow oxygen nasal cannula</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

